Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
A fulminating disease of neonates in which there is extensive mucosal ulceration, pseudomembrane formation, submucosal hemorrhage, and necrosis usually of the right colon, cecum, terminal ileum, and appendix, possibly due to perinatal intestinal ischemia and bacterial invasion. Progression can lead to necrosis, perforation and/or scarring of the intestinal tract.
Biomarker and diagnostic research for perinatal necrotizing enterocolitis has been reported in the published literature.
46 clinical trials registered, 13 recruiting. Interventions under study include other interventions, biologic therapy, drug therapy, and gene therapy. Pipeline includes 2 PHASE4, 2 PHASE3, 2 PHASE2. Research is sponsored by a mix of industry and academic institutions.
NCT ID | Title | Phase | Sponsor | Status |
|---|---|---|---|---|
[NCT06315738](https://clinicaltrials.gov/study/NCT06315738) |
Data assembled from 3 of 12 sources · Last updated Sep 19, 2026, 4:55 AM UTC
Study to Assess the Safety, Tolerability, and Preliminary Efficacy of ST266 in Infants With Necrotizing Enterocolitis (NEC) |
PHASE1 |
Noveome Biotherapeutics, formerly Stemnion |
RECRUITING |
[NCT07273643](https://clinicaltrials.gov/study/NCT07273643) | Characterization of Extracellular Vesicles From the Cord Blood of Extremely Preterm New Borns and Their Correlation With Severe Morbidity and Mortality | — | University Hospital, Montpellier | RECRUITING |
[NCT00747851](https://clinicaltrials.gov/study/NCT00747851) | NETs: Protection or Harm in Neonatal Inflammation or Infection | — | University of Utah | RECRUITING |
[NCT05213806](https://clinicaltrials.gov/study/NCT05213806) | WithHolding Enteral Feeds Around Blood Transfusion (International) | NA | IWK Health Centre | RECRUITING |
[NCT07152106](https://clinicaltrials.gov/study/NCT07152106) | Amniotic Fluid & the Preterm Gut | — | Maxima Medical Center | RECRUITING |
317 publications have been identified in PubMed for perinatal necrotizing enterocolitis. Kisho has analyzed 56 by research type. Research spans Review / Meta-Analysis (38%), Epidemiology / Natural History (29%), and Clinical Trial Publication (16%).
Research Type | Count | % of Total |
|---|---|---|
Research summaries | 21 | 38% |
Disease patterns and progression | 16 | 29% |
Clinical study results | 9 | 16% |
Laboratory research | 8 | 14% |
Testing and diagnosis research | 1 | 2% |
Patient case studies | 1 | 2% |
Sajankila N (2026). [PMID: 40877707](https://pubmed.ncbi.nlm.nih.gov/40877707/). *Pediatr Res*. [Basic Science / Preclinical]
Dang D (2026). [PMID: 40514414](https://pubmed.ncbi.nlm.nih.gov/40514414/). *Pediatr Res*. [Epidemiology / Natural History]
Chetta KE (2026). [PMID: 42049590](https://pubmed.ncbi.nlm.nih.gov/42049590/). *Semin Perinatol*. [Review / Meta-Analysis]
Kusuda S (2025). [PMID: 40121271](https://pubmed.ncbi.nlm.nih.gov/40121271/). *Sci Rep*. [Clinical Trial Publication]
Sankar MN (2025). [PMID: 40090543](https://pubmed.ncbi.nlm.nih.gov/40090543/). *J Pediatr*. [Clinical Trial Publication]
Mozes G (2025). [PMID: 41051988](https://pubmed.ncbi.nlm.nih.gov/41051988/). *J Vis Exp*. [Basic Science / Preclinical]
Shan Y (2025). [PMID: 40181295](https://pubmed.ncbi.nlm.nih.gov/40181295/). *BMC Pediatr*. [Epidemiology / Natural History]
van de Meent M (2025). [PMID: 39694164](https://pubmed.ncbi.nlm.nih.gov/39694164/). *Am J Obstet Gynecol*. [Epidemiology / Natural History]
Price L (2025). [PMID: 40280799](https://pubmed.ncbi.nlm.nih.gov/40280799/). *Semin Fetal Neonatal Med*. [Review / Meta-Analysis]
Lee JY (2025). [PMID: 40445942](https://pubmed.ncbi.nlm.nih.gov/40445942/). *PLoS One*. [Epidemiology / Natural History]
AI-curated news mentioning perinatal necrotizing enterocolitis
Updated Aug 15, 2026
Research indicates that berberine may reduce brain injury associated with necrotizing enterocolitis by modulating the TLR4/MyD88/NF-κB/NLRP3 signaling pathway. This discovery could inform future therapeutic strategies for affected infants.
A study investigates the impact of intraoperative hypothermia on short-term outcomes in neonatal necrotizing enterocolitis. The findings contribute to understanding treatment approaches for this serious condition affecting newborns.
Recent research highlights the role of the SUCNR1/HIF-1α/BNIP3 axis in exacerbating necrotizing enterocolitis through succinate-induced apoptosis in intestinal epithelial cells. This discovery could inform future therapeutic strategies for this serious condition.